药物研究
CHEN Hongyan;WEN Hangyuan;GENG Miao;WANG Jianhua;HUANG Zhengming;YANG Xinbo
ABSTRACTObjectiveTo investigate the effects and mechanism of lianqixiaoke capsules (LXC) on advanced glycation endproducts(AGEs) and the oxidative stress injury in kidneys of STZinduced diabetic rats.MethodsThe Wistar rats were randomly divided into 6 groups, which were the control group fed with chow food, the other groups given with high fat diets.After 4 weeks, the rats except the control were intraperitoneally injected with streptozotocin (STZ)30 mg8226;kg1.The diabetic rats were treated with LXC at high, middle and low doses, metformin and vehicle, respectively.Eight weeks later, the blood glucose,UALB,SOD,MDA, AGEs,TGFβ1 and TNFα were measured.And the kidney was removed for pathological analysis.Results In the LXC group, FBG was(18.67±2.52) mmol8226;L1, MDA was(1.78±0.39) nmol8226;g1, UmALB was (41.84±8.23) μg8226;L1,AGEs was (116.91±19.96) ng8226;mL1, TGFβ1 was (33.22±9.94) ng8226;mL1,TNFα was (54.01±17.55) pg8226;mL1,all of which were declined and SOD was(190.11±15.88) U8226;mg1,which was elevated.The function and pathological changes in kidney were significantly improved compared to those in the control group, especially for the high dose of LXC (P<0.05).ConclusionThe model of diabetic nephropathy in diabetic rats is successfully set up by feeding fat diet and injecting low dose of STZ in rats.LXC decreases AGEs and relieves diabetic kidney injury, the mechanism of which could be associated with inhibiting production of AGEs, lowering oxidative stress and inflammatory factors.